Effects of Paraxanthine and Caffeine on Sleep, Locomotor Activity, and Body Temperature in Orexin/Ataxin-3 Transgenic Narcoleptic Mice
Author(s) -
Masashi Okuro,
Nobuhiro Fujiki,
Nozomu Kotorii,
Yuji Ishimaru,
Pierre Sokoloff,
Seiji Nishino
Publication year - 2010
Publication title -
sleep
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.222
H-Index - 207
eISSN - 1550-9109
pISSN - 0161-8105
DOI - 10.1093/sleep/33.7.930
Subject(s) - orexin , caffeine , paraxanthine , narcolepsy , sleep (system call) , endocrinology , medicine , genetically modified mouse , chemistry , transgene , pharmacology , modafinil , biochemistry , gene , neuropeptide , metabolism , receptor , cytochrome p450 , cyp1a2 , computer science , operating system
Caffeine, an adenosine A1 and A2a receptor antagonist, is a widely consumed stimulant and also used for the treatment of hypersomnia; however, the wake-promoting potency of caffeine is often not strong enough, and high doses may induce side effects. Caffeine is metabolized to paraxanthine, theobromine, and theophylline. Paraxanthine is a central nervous stimulant and exhibits higher potency at A1 and A2 receptors, but has lower toxicity and lesser anxiogenic effects than caffeine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom